Skip to content
  1. Stocks
  2. Pharma & Healthcare
  3. Adeshwar Medite

Adeshwar Medite share price

NSE: ADESHWARPharma & HealthcareMedical Instruments & Supplies

Adeshwar Medite at a glance

With a market capitalisation of ₹21 Cr, it ranks 3567th by market cap among the 4,183 NSE companies Pivot tracks (a small-cap company by SEBI's rank bands). It belongs to the Pharma & Healthcare sector; its industry is Medical Instruments & Supplies.

Its return on equity was 5.6% in FY25. Promoters held 57.68% of the company as of 31 Mar 2026.

Key numbers

Market cap
₹21 CrRank 3567 on NSE
Price to book
0.66×FY25
ROE
5.6%FY25
ROCE
10.5%FY25
Debt to equity
0.34FY25
Net profit margin
2.5%FY25
Book value / share
₹25.61FY25

Returns to 22 Oct 2026

Period1 day1 week1 month3 months1 year
Price change—————

Adeshwar Medite financials

Annual, ₹ crore unless stated · fiscal years ending March
ItemFY20FY21FY22FY23FY24FY25
Revenue₹56 Cr₹66 Cr₹65 Cr₹82 Cr₹80 Cr₹84 Cr
Operating profit₹3 Cr₹2 Cr₹1 Cr₹3 Cr₹3 Cr₹3 Cr
Net profit₹2 Cr₹2 Cr₹1 Cr₹2 Cr₹2 Cr₹2 Cr
EPS (₹)₹3.83₹1.59₹0.55₹1.44₹1.39₹1.43
Cash from operations₹1 Cr₹3 Cr−₹2 Cr₹6 Cr₹4 Cr₹4 Cr
Total debt₹6 Cr₹5 Cr₹4 Cr₹2 Cr₹1 Cr₹2 Cr
Shareholders' equity₹19 Cr₹21 Cr₹31 Cr₹33 Cr₹35 Cr₹37 Cr

Adeshwar Medite shareholding pattern

% of shares held, by quarter end
Holder30 Sep 202331 Mar 202430 Sep 202431 Mar 202530 Sep 202531 Mar 2026
Promoters42.65%42.65%57.55%57.55%57.55%57.68%
Non-institutions57.35%57.35%42.45%42.45%42.45%42.32%

Adeshwar Medite vs peers

The listed Pharma & Healthcare companies nearest to Adeshwar Medite by market capitalisation.

CompanyPrice1 day1 yearMarket capP/EROE
TRABITransgene Biote———₹23 Cr——
HAMPSHamps Bio———₹22 Cr——
VINRKLBRekvina Labs———₹22 Cr——
ADESHWARAdeshwar Medite———₹21 Cr——
MAITRIMaitri———₹19 Cr——
DESHRAKDesh Rakshak———₹19 Cr——
NIDANNidan Lab₹12.650.00%−31.3%₹18 Cr——

Ask anything about Adeshwar Medite

Pivot answers on the live chart with evidence you can check, and tests strategies against ADESHWAR's own history. Try: “Why has ADESHWAR moved over the last three months?” · “Backtest a 50-day moving-average crossover on ADESHWAR over five years” · “Compare ADESHWAR with TRABI on margins and valuation”

Start free

Frequently asked questions about Adeshwar Medite

What is the market cap of Adeshwar Medite?

Adeshwar Medite's market capitalisation is ₹21 Cr (₹21 Cr) at the 22 Oct 2026 close, ranking 3567th among the NSE companies Pivot tracks.

What is the ROE and ROCE of Adeshwar Medite?

Return on equity was 5.6% in FY25 and return on capital employed was 10.5% in FY25 (standalone figures).

Is Adeshwar Medite a debt-free company?

No. Adeshwar Medite's debt-to-equity ratio was 0.34 in FY25, with total debt of ₹2 Cr.

What is the shareholding pattern of Adeshwar Medite?

As of 31 Mar 2026: promoters 57.68%, non-institutions 42.32%.

Who are Adeshwar Medite's competitors?

The listed Pharma & Healthcare companies closest to Adeshwar Medite by market cap are Transgene Biote, Hamps Bio, Rekvina Labs, Maitri, Desh Rakshak and Nidan Lab.

Is Adeshwar Medite a good stock to buy?

Pivot does not give buy or sell recommendations. This page sets out Adeshwar Medite's price history, valuation, profitability, quarterly results and ownership so you can judge it yourself, and Pivot's chart lets you test a strategy on ADESHWAR against its own history before risking money. This is analysis, not financial advice.

Sources and method

Prices: NSE daily closes to 22 Oct 2026 (returns and ratios at the 22 Oct 2026 close). Fundamentals: company filings via Moneycontrol, consolidated where available. Shareholding: exchange shareholding-pattern filings. The 52-week range uses intraday highs and lows; the chart marks closing prices. P/E is the last close over trailing twelve-month EPS. Market-cap rank is among the 4,183 NSE companies Pivot tracks; SEBI's bands call the top 100 large-cap and the next 150 mid-cap. Figures marked “—” are not available rather than zero. This is analysis, not financial advice.

More: all Pharma & Healthcare stocks · companies starting with A · all NSE stocks · this page as text